[PDF][PDF] Severe COVID-19 is marked by a dysregulated myeloid cell compartment

…, F Machleidt, A Uhrig, LB de Jarcy, L Jürgens… - Cell, 2020 - cell.com
Coronavirus disease 2019 (COVID-19) is a mild to moderate respiratory tract infection, however,
a subset of patients progress to severe disease and respiratory failure. The mechanism …

[PDF][PDF] A time-resolved proteomic and prognostic map of COVID-19

…, LB de Jarcy, MS Stegemann, M Pfeiffer, L Jürgens… - Cell systems, 2021 - cell.com
COVID-19 is highly variable in its clinical presentation, ranging from asymptomatic infection
to severe organ damage and death. We characterized the time-dependent progression of …

[HTML][HTML] Ultra-fast proteomics with Scanning SWATH

…, G Ivosev, F Wasim, A Zelezniak, L Jürgens… - Nature …, 2021 - nature.com
Accurate quantification of the proteome remains challenging for large sample series and
longitudinal experiments. We report a data-independent acquisition method, Scanning SWATH, …

[HTML][HTML] Monkeypox in-patients with severe anal pain

F Pfäfflin, D Wendisch, R Scherer, L Jürgens… - Infection, 2023 - Springer
Berlin is amongst the cities most affected by the current monkeypox outbreak. Here, we report
clinical characteristics of the first patients with confirmed monkeypox admitted to our center…

[HTML][HTML] A proteomic survival predictor for COVID-19 patients in intensive care

…, MS Stegemann, M Pfeiffer, L Jürgens… - PLOS Digital …, 2022 - journals.plos.org
Global healthcare systems are challenged by the COVID-19 pandemic. There is a need to
optimize allocation of treatment and resources in intensive care, as clinically established risk …

Suppressive myeloid cells are a hallmark of severe COVID-19

…, F Machleidt, A Uhrig, LB de Jarcy, L Jürgens… - MedRxiv, 2020 - medrxiv.org
‘Severe Acute Respiratory Syndrome - Coronavirus-2’ (SARS-CoV-2) infection causes
Coronavirus Disease 2019 (COVID-19), a mild to moderate respiratory tract infection in the …

A time-resolved proteomic and diagnostic map characterizes COVID-19 disease progression and predicts outcome

…, LB de Jarcy, MS Stegemann, M Pfeiffer, L Jürgens… - MedRxiv, 2020 - medrxiv.org
COVID-19 is highly variable in its clinical presentation, ranging from asymptomatic infection
to severe organ damage and death. There is an urgent need for predictive markers that can …

[HTML][HTML] Impact of dexamethasone on SARS-CoV-2 concentration kinetics and antibody response in hospitalized COVID-19 patients: results from a prospective …

…, S Schmidt, A Krannich, C von Kalle, L Jürgens… - Clinical Microbiology …, 2021 - Elsevier
Objectives Dexamethasone has become the standard of care for severe coronavirus disease
2019 (COVID-19), but its virological impact is poorly understood. The objectives of this …

[PDF][PDF] Langzeitnachbeobachtungen von kombinierten Tele-/High-Dose-Rate-Brachytherapien beim Prostatakarzinom im Behandlungszeitraum von 06.2004 bis …

L Jürgens - 2015 - macau.uni-kiel.de
Die Prostata, umgangssprachlich auch Vorsteherdrüse genannt, ist eine etwa kastaniengroße
Drüse, welche im Normalfall zwischen 20 und 40g wiegt. Sie gehört wie die paarig …

Suppressive myeloid cells are a hallmark of severe COVID-19 (preprint)

…, F Machleidt, A Uhrig, LB de Jarcy, L Jürgens… - 2020 - pesquisa.bvsalud.org
Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) infection causes Coronavirus
Disease 2019 (COVID-19), a mild to moderate respiratory tract infection in the majority …